Welcome to the tag category page for FDA Approval!
Wegovy is a prescription medication for adults with obesity or overweight. It contains semaglutide and works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food. It is used as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management. Patients taking Wegovy lost an average of 35 lbs over 68 weeks, and 83% of them lost 5% or more of their weight. Wegovy comes in 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg pens, while Ozempic is available in 0.25 mg, 0.5 mg, and 1.0 mg pens. It may take several weeks or months before a person notices weight loss or a decrease in appetite from Wegovy.
